VNRX: Zacks SCR Refreshes its Latest Report With Volition's Financials, Prices, EPS Estimates, Market Statistics and Target Price Adjusted for 1-for-20 Reverse-Split [Yahoo! Finance]
VolitionRX Limited (VNRX)
NASDAQ:AMEX Investor Relations:
ir.volitionrx.com
Company Research
Source: Yahoo! Finance
VolitionRx's (NYSE: VNRX) Management's primary operational goal for 2026 continues to be securing licensing agreements for its Nu.Q assays for human diagnostic applications. The operational cost cutting program will continue into 2026. Initiatives in Europe are seeking: 1) a regimen for reimbursement in France [supported by studies using Nu.Q lung cancer test ] and a transition of Nu.Q NETs from IVDD to the new IVDR requirements under the CE mark [supported by the French DETECSEPS (sepsis) program ]. A Special Meeting of Stockholders approved a reverse-split. Subsequently, the Board of Directors authorized a 1-for-20 reverse-split that will become effective on April 28 th RECENT NEWS Nu.Q Vet (Feline): During 2026, Management expects to publish a feline lymphoma clinical study in a peer-reviewed journal, which should trigger a $5 million milestone payment from Antech/Heska. Nu.Q Vet (Canine): During the first quarter of 2026, the ChLIA (CHemiLuminescent ImmunoAssay) ver
Show less
Read more
Impact Snapshot
Event Time:
VNRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VNRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VNRX alerts
High impacting VolitionRX Limited news events
Weekly update
A roundup of the hottest topics
VNRX
News
- Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis TestingPR Newswire
- VolitionRx Announces Acceptance of Compliance Plan by NYSE AmericanPR Newswire
- Volition Launches rNuQ™ Webshop Broadening Product RangePR Newswire
- VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]Yahoo! Finance
- VolitionRx Limited (VNRX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
VNRX
Earnings
- 3/31/26 - Miss
VNRX
Sec Filings
- 4/28/26 - Form 8-K
- 4/23/26 - Form 8-K
- 4/21/26 - Form 8-K
- VNRX's page on the SEC website